Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Cardiol. Aug 26, 2013; 5(8): 288-294
Published online Aug 26, 2013. doi: 10.4330/wjc.v5.i8.288
Figure 2
Figure 2 Changes in use of guideline-recommended treatments in each compelling indication between 1999 and 2009 in both CARDIOTENS registries. ACEI: Angiotensin-converter enzyme inhibitors; AF: Atrial fibrillation; ARB: Angiotensin-receptor blockers; CHD: Coronary heart disease; HF: Heart failure; OAC: Oral anticoagulation. Data presented as percentage (99%CI).